16
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
TP1369L | [Sar9,Met(O2)11]-Substance P acetate | [Sar9,Met(O2)11]-Substance P acetate(110880-55-2 free base) | Neurokinin receptor |
[Sar9,Met(O2)11]-Substance P acetate is a tachykinin NK1 receptor selective agonist. [Sar9,Met(O2)11]-Substance P acetate is a selective tachykinin NK1 receptor agonist.[Sar9,Met(O2)11]-Substance P acetate and septide (1... | |||
T7828 | [Sar9,Met(O2)11]-Substance P | Bhsar-sp,NA | Neurokinin receptor |
[Sar9,Met(O2)11]-Substance P (NA) is an agonist of NK1 receptor. | |||
TP1369 | [Sar9,Met(O2)11]-Substance P TFA(110880-55-2,free) | [Sar9,Met(O2)11]-Substance P TFA | |
[Sar9,Met(O2)11]-Substance P TFA is a selective tachykinin NK1 receptor agonist.[Sar9,Met(O2)11]-Substance P and septide (10-100 pmol per rat, i.c.v.) are equipotent in increasing mean arterial blood pressure (MAP) and h... | |||
T9052 | XL092 | CL-092,JUN04542 | VEGFR , c-Met/HGFR , TAM Receptor |
XL092 (JUN04542) is an Axl Mer cMet KDR inhibitor for the treatment of Axl and Mer receptor tyrosine kinase- dependent disorders. | |||
T75769 | [Sar9,Met(O2)11]-Substance P TFA | ||
[Sar9,Met(O2)11]-Substance P TFA is a tachykinin NK 1 receptor selective agonist. | |||
T25098 | Antiflammin P2 | Hdmnkvldl,Antiflamin 2,His-asp-met-asn-lys-val-leu-asp-leu | |
Antiflammin P2 is a nonapeptide fragment of lipocortin I which has no phospholipase A2 inhibitory and anti-inflammatory activity. | |||
TQ0210 | Savolitinib | AZD-6094,Volitinib,HMPL-504 | c-Met/HGFR |
Savolitinib (Volitinib) (AZD-6094) is an effective, selective, and orally bioavailable c-Met inhibitor (IC50s: 5 nM/3 nM for c-Met/p-Met). | |||
T77575 | P-gb-IN-1 | P-gp | |
P-gb-IN-1 is a potent P-glycoprotein (P-gp) inhibitor that exhibits reverse activity by inhibiting P-gp outflow. P-gb-IN-1 has been shown to inhibit P-gp by hydrogen bonding with residues Asn 721 and Met 986. P-gb-IN-1 s... | |||
TP1862L | [Sar9] Substance P acetate(77128-75-7 free base) | Neurokinin receptor | |
[Sar9]-Substance P acetate is one of NK-1 receptor agonist. The action of SP on progesterone metabolism was mimicked by the rNK1-specific agonist [Sar-9,Met(O2)11]-SP. | |||
T76452 | Gly-Leu-Met-NH2 | ||
Gly-Leu-Met-NH2 is a C-terminal tripeptide of Substance P ( Substance P ). Substance P is a neuropeptide [1] . | |||
T15384 | Glesatinib | MGCD265 | c-Met/HGFR |
Glesatinib is an orally active and potent dual inhibitor of MET/SMO. Glesatinib is also a tyrosine kinase inhibitor. It antagonizes P-glycoprotein mediated multidrug resistance (MDR) in NSCLC. | |||
T76449 | Substance P (alligator) | ||
Substance P (alligator), a neuropeptide derived from alligator, possesses a primary structure delineated as Arg-Pro-Arg-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2 [1]. | |||
T15383 | Glesatinib hydrochloride | MGCD265 hydrochloride | c-Met/HGFR |
Glesatinib hydrochloride is an orally active and potent dual inhibitor of MET/SMO. Glesatinib hydrochloride is also a tyrosine kinase inhibitor. It antagonizes P-glycoprotein mediated multidrug resistance (MDR) in NSCLC. | |||
T70456 | Nolpitantium Free Base | ||
Nolpitantium Free Base is a highly selective nonpeptide antagonist of neurokinin-1 (NK1) receptor. Nolpitantium potently, selectively and competitively inhibited substance P binding to NK1 receptors from various animal s... | |||
TP1862 | [Sar9] Substance P | ||
[Sar9]-Substance P is one of NK-1 receptor agonist. The action of SP on progesterone metabolism was mimicked by the rNK1-specific agonist [Sar-9,Met(O2)11]-SP. | |||
T29186 | YM49598 | YM-49598,YM 49598 | |
YM49598 is a tachykinin receptor antagonist. YM49598 exhibited high binding affinities at NK(1) (pK(i) = 9.09 +/- 0.02) and NK(2) (pK(i) = 9.94 +/- 0.03) receptors, respectively. YM49598 was almost inactive but produced ... |